Fenofibrate and renal impairment Patient Reports February 11, 2012

Fenofibrate Side Effects Report #5874327-0
Fenofibrate side effect was reported by a Consumer or non-health professional from GERMANY on Aug 29, 2008. Female patient, 48 years of age, was diagnosed with lipids increased and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: asthenia, hepatic function abnormal, myalgia, renal impairment, rhabdomyolysis, urine colour abnormal, urine output decreased. Fenofibrate dosage: unknown. Patient was hospitalized. Patient recovered.

Fenofibrate Side Effects Report #4924699-6
Fenofibrate side effect was reported by a Health Professional from AUSTRIA on Feb 07, 2006. Male patient, 75 years of age, was diagnosed with hypertriglyceridaemia, diabetes mellitus inadequate control and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, diabetes mellitus inadequate control, liver function test abnormal, metabolic disorder , myopathy, renal impairment. Fenofibrate dosage: 200 MG; QD; PO. During the same period patient was treated with ROSIGLITAZONE, PHENPROCOUMON, VALSARTAN, SYMPATHOMIMETICS, METFORMIN. Patient was hospitalized. Patient recovered.

Fenofibrate Side Effects Report #5647925-7
Fenofibrate side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2008. Male patient, 60 years of age, weighting 253.5 lb, was diagnosed with hypertriglyceridaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, glomerular filtration rate decreased, renal impairment. Fenofibrate dosage: unknown. During the same period patient was treated with FUROSEMIDE, ASPIRIN, AMLODIPINE, PANTOPRAZOLE. Patient recovered.

Fenofibrate Side Effects Report #5395758-1
Fenofibrate side effect was reported by a Health Professional from GERMANY on July 16, 2007. Male patient, 51 years of age, was diagnosed with hypertriglyceridaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: renal impairment. Fenofibrate dosage: unknown. During the same period patient was treated with THIAMAZOLE, LEVOTHYROXINE, SULPIRIDE, FLUVOXAMINE MALEATE, ALPRAZOLAM. Patient recovered.


Fenofibrate Side Effects Report #5504430-6
Fenofibrate side effect was reported by a Health Professional from GERMANY on Oct 24, 2007. Female patient, 76 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: hepatic function abnormal, renal impairment. Fenofibrate dosage: unknown. During the same period patient was treated with TOCOPHEROL CONCENTRATE CAP, TELMISARTAN, MITIGLINIDE CALCIUM HYDRATE. Patient was hospitalized. Patient recovered.

Fenofibrate Side Effects Report #5517507-6
Fenofibrate side effect was reported by a Health Professional from GERMANY on Nov 08, 2007. Female patient, 76 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: hepatic function abnormal, renal impairment. Fenofibrate dosage: unknown. During the same period patient was treated with TOCOPHEROL CONCENTRATE CAP, TELMISARTAN, MITIGLINIDE CALCIUM HYDRATE. Patient was hospitalized. Patient recovered.

Fenofibrate Side Effects Report #5563942-X
Fenofibrate side effect was reported by a Health Professional from GERMANY on Dec 07, 2007. Female patient, 74 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: hyperkalaemia, renal impairment. Fenofibrate dosage: unknown. During the same period patient was treated with TELMISARTAN, AZELNIDIPINE, TEPRENONE, NATEGLINIDE, SENNOSIDE A, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Fenofibrate Side Effects Report #6127785-0
Fenofibrate side effect was reported by a Health Professional from GERMANY on Mar 13, 2009. Female patient, 57 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: renal impairment, rhabdomyolysis. Fenofibrate dosage: unknown. During the same period patient was treated with VALSARTAN, DIPYRIDAMOLE, AMLODIPINE BESYLATE. Patient recovered.

Fenofibrate Side Effects Report #6134957-8
Fenofibrate side effect was reported by a Health Professional from GERMANY on Mar 20, 2009. Female patient, 57 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: liver function test abnormal, renal impairment, rhabdomyolysis. Fenofibrate dosage: unknown. During the same period patient was treated with VALSARTAN, DIPYRIDAMOLE, AMLODIPINE BESYLATE. Patient recovered.


Fenofibrate Side Effects Report #5780995-4
Fenofibrate side effect was reported by a Physician from GERMANY on June 12, 2008. Female patient, 63 years of age, was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: asthenia, renal impairment, scleroderma . Fenofibrate dosage: unknown. During the same period patient was treated with TIOTROPIUM BROMIDE, OLMESARTAN MEDOXOMIL, ALDACTAZINE, CHONDROITIN SULPHATE, COLECALCIFEROL. Patient was hospitalized. Patient recovered.

Fenofibrate Side Effects Report #5655648-3
Fenofibrate side effect was reported by a Consumer or non-health professional from GERMANY on Feb 28, 2008. Female patient, 56 years of age, was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: hypercholesterolaemia, hypertension, hypertriglyceridaemia, renal impairment, rhabdomyolysis. Fenofibrate dosage: unknown. During the same period patient was treated with CYCLOSPORINE, MYCOPHENOLATE MOFETIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, OMEPRAZOLE, FUROSEMIDE, BEZAFIBRATE. Patient was hospitalized. Patient recovered.